filmov
tv
Dr. Meeks on Mutations Associated With T1 Progression in Bladder Cancer
Показать описание
OncLive
cancer
oncology
Рекомендации по теме
0:01:50
Dr. Meeks on Mutations Associated With T1 Progression in Bladder Cancer
0:01:09
Joshua Meeks’ Lab: The Epigenetics of Bladder Cancer
0:01:10
Dr. Meeks on the Importance of p53 and Rb1 in Bladder Cancer
0:01:47
Dr. Meeks on the Genomics of Bladder Cancer
0:00:33
Copy of Dr. Meeks on the Genomics of Bladder Cancer
0:02:02
Dr. Meeks Discusses Smoking Status in Bladder Cancer
0:01:56
Dr. Pemmaraju on the Challenges of Targeting TP53 Mutations in MDS/AML
0:11:35
Update on First Biomarker-Directed Trial of Non-Muscle-Invasive Bladder Cancer
0:00:36
Copy of Dr. Meeks Discusses Smoking Status in Bladder Cancer
0:51:15
Practice-Changing Articles in Bladder Cancer
0:00:42
Matthew I. Milowsky, MD, on the role of genomics in understanding heterogeneity in bladder cancer
0:56:50
Time 4 Genetics Webinar: Autism: What Can Genetics Tell Us?
0:54:29
Bladder Cancer Immunotherapy Series: Immunotherapy: From Research to Practice #1
1:55:30
AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Deliver...
0:42:41
Immuno - Oncoloy: A New Class Of Drugs
0:06:14
Residual mutant p53 activity linked to cancer survival in males
0:24:54
Genomics and How They are Used in Precision Medicine for Bladder Cancer
0:01:25
Dr. Daneshmand on Blue Light Cystoscopy for Bladder Cancer
0:57:05
Highlights in Urologic Oncology from ASCO 2022
0:02:50
A Therapeutic Revolution: Immunotherapy for Bladder Cancer
0:08:49
Non-Muscle-Invasive Bladder Cancer
0:57:05
Highlights in Urologic Oncology From 2022 ASCO GU Cancers Symposium
0:04:15
Prion like aggregation on mutant p53 in cancer
0:03:04
Benefits of T1 substaging for NMIBC
0:01:50
0:01:09
0:01:10
0:01:47
0:00:33
0:02:02
0:01:56
0:11:35
0:00:36
0:51:15
0:00:42
0:56:50
0:54:29
1:55:30
0:42:41
0:06:14
0:24:54
0:01:25
0:57:05
0:02:50
0:08:49
0:57:05
0:04:15
0:03:04